Abstract
Routine and microscopic examinations of the left ear canal revealed the presence of a blue-hued, circumferential swelling that prevented clear visualization ofthe tympanic membrane.Multiple needle aspiration s of the lesion yielded no aspirat e and caused no notable decompression of the lesion. Audiometric testing reve aled a severe to profound, high-frequency sensorineural hearing loss in the right ear and a mixed loss in the left ear. Prior to a planned biops y, computed tomography (CT) of the tempo ral bone clearly deline ated the outline of a soft-tiss ue lesion confined entirely to the left ear canal (figure I).
Histologic examination of the biop sy specimen revealed that it was a diffuse large-cell lymphoma (figure 2). Parti al infiltration of the fibroconnective tissue by atypical mononuclear cells was seen. The cells had large nuclei , frequent multiple nucleoli , and a moderate amount of cytoplasmhistologic feature s that are consistent with diffuse large-cell lymphoma. The surrounding tissue exhibited evidence of inflamm ation. Immunophenotypic analysis of the tumor was performed via a three-step immunoperoxidase method . The paraffin tissue sections were stained with antibodies to C020 (L26), C03 , C068 (PGM-l) , lyso zyme, C043 (Leu 22), CAM 5.2, andAEl/AE3.
The tumo r cells were negative for C03 (T cells), C068, lysozyme (myeloid cells), CAM 5.2 (epitheli al cells), and AEl/AE3, which effectively ruled out carcinoma, granulocytic sarcom a, and T cell lymphoma. However, the tumor cell s were positive for C020 (L26), indicating that they were of B cell origin. In addition , the tumor cells coexpressed C043 . Coexpression of C043 and a B cell marker is comp atible with a B cell lymphoma. A staging workup was negative for any other site of involvement.
The patient was treated with external-beam radiation to 5,040 cGy. She remained disease-fre e throu ghout 9 years of follow-up. cli nica l and histologic features. Irrespect ive of ce ll type or clas sification, the single most stIikingclinical feature ofthese lymp hoproliferat ive neop lasms is clearly the presence of lymph adenopathy. Ex tra nodal invo lveme nt, altho ug h ra re in Hodgkin' s disease, may be present in as many as 30% of patient s with non-Hodgkin's lymph oma; the head and neck region is second only to the gastrointestinal tract as the most common site of involvement. JO Lymphadenopathy is gene rally associated with extranodal involvement at some point during the co urse of the dise ase. Sh ould an extrano dal site prove to be the so le locus of path ology, the lesion wou ld likely be identified as a primary extranodal lymphom a."
Discussion
Although uncommon, a number of cases of temporal bone lymp homas have bee n reported.P In most of them, the lymph oma wa s me tastatic. As mentioned, sites of primary lymph om as or iginating in the temporal bone area have bee n reported to includ e the middl e ea r,3-5mastoid.v intern al auditory ca nal," and external auditory ca nal.F' Of these sites, the middle ear and mastoid appea r to be the most co mmo n. Sy mptoms co mmo nly assoc iated with these temp oral bone neopl asm s tend to be site-specific. Alth ough patient s may present with any co mbination of typical earc omplaints, cer tain circums tances-such as fac ial ner ve paralysis or an infec tion that fai ls to respo nd to appro priate medical interve ntio n-sho uld raise the specter of a possible underlying malign an cy," • Reconstru ction of the ossicular cha in where cement can be used to re pair the bony ossicles in the ir norm al position • Acoustic meatal wall reco nstr uction • Cementatio n of cochlear implant electrodes Se re n ocern T.l1 was designed specifically for non-weight bearing applications in otologic surgery including:
Use Se re nocem'Yto bridge the eroded incus with the stapes
Serenoce ----Otologic Cement -----
A rise in the incidence of non-Hod gkin's lymph oma is well recognized in patients whose immune status is altered. Non-H odgkin's lymphoma has taken on added relevance because of its prominen ce as a malignancy related to acquired immunodeficiency syndrome (AIDS). With an estimated 200-fold increase beyond expected rates in patients infected with human immunodeficiency virus (HIV), non-Hodgkin 's lymphom a has emerged as the seco nd most common malignancy among this group. Virtually all cases ofHIV-associated non-Hodgkin's lymphom a are ofB cell origin; appro ximately half of these cases are extranodal in presentation .II These neoplasms typically progress rapidly and generally display high-grade histopathology. A wide spectrum of uncomm on, unexpected extranodal sites has been described in cases of AIDS-rel ated non-Hod gkin 's lymphoma.'!"It would clearly serve us well not to overlook the possibility of AIDS in a patient with non-Hodgkin 's lymphoma in an unusual extranod al site.
